Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure. (Q48408264)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 August 2012

Language	Label	Description	Also known as
English	Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure.	scientific article published on 16 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

0 references

author name string

Christoph Birner

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Coskun Ulucan

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Mona Bratfisch

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Tobias Götz

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Alexander Dietl

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Frank Schweda

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Günter A Riegger

7

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Andreas Luchner

8

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

publication date

16 August 2012

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Naunyn-Schmiedeberg's Archives of Pharmacology

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

385

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

11

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

1117-1125

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

https://scigraph.springernature.com/pub.10.1007/s00210-012-0791-6

0 references

A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Differential expression of potassium channels and abnormal conduction in experimental tachycardia-induced heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Combined neutral endopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Experimental heart failure produced by rapid ventricular pacing in the dog.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Brain natriuretic peptide and neutral endopeptidase inhibition in left ventricular impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Angiotensin II in the evolution of experimental heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

The natriuretic peptides in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Effect of neutral endopeptidase inhibitor in rats with congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Vasopeptidase inhibition for blood pressure control: emerging experience

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Vasopeptidase inhibition: effective blood pressure control for vascular protection

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Cytokines--causes, players or bystanders in heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-012-0791-6

21 January 2018

Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics and clinical relevance of animal models of heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left ventricular and myocyte structure and function following chronic ventricular tachycardia in rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic effect of combined treatment with omapatrilat and adrenomedullin on the progression of heart failure in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell surface metallopeptidases involved in blood pressure regulation: structure, inhibition and clinical perspectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in men

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22895639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00210-012-0791-6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22895639

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48408264&oldid=1414712015"